EP2142195A4 - Composition for promoting the maintenance and function of muscle-specific progenitor cells - Google Patents

Composition for promoting the maintenance and function of muscle-specific progenitor cells

Info

Publication number
EP2142195A4
EP2142195A4 EP07719475A EP07719475A EP2142195A4 EP 2142195 A4 EP2142195 A4 EP 2142195A4 EP 07719475 A EP07719475 A EP 07719475A EP 07719475 A EP07719475 A EP 07719475A EP 2142195 A4 EP2142195 A4 EP 2142195A4
Authority
EP
European Patent Office
Prior art keywords
muscle
promoting
maintenance
composition
function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07719475A
Other languages
German (de)
French (fr)
Other versions
EP2142195A1 (en
Inventor
Marvin Heuer
Ken Clement
Shan Chaudhuri
Michele Molino
Philip Apong
Jason Peters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northern Innovations and Formulations Corp
Original Assignee
Northern Innovations and Formulations Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northern Innovations and Formulations Corp filed Critical Northern Innovations and Formulations Corp
Publication of EP2142195A1 publication Critical patent/EP2142195A1/en
Publication of EP2142195A4 publication Critical patent/EP2142195A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP07719475A 2007-04-04 2007-04-04 Composition for promoting the maintenance and function of muscle-specific progenitor cells Withdrawn EP2142195A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA2007/000545 WO2008122098A1 (en) 2007-04-04 2007-04-04 Composition for promoting the maintenance and function of muscle-specific progenitor cells

Publications (2)

Publication Number Publication Date
EP2142195A1 EP2142195A1 (en) 2010-01-13
EP2142195A4 true EP2142195A4 (en) 2011-10-12

Family

ID=39830423

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07719475A Withdrawn EP2142195A4 (en) 2007-04-04 2007-04-04 Composition for promoting the maintenance and function of muscle-specific progenitor cells

Country Status (4)

Country Link
EP (1) EP2142195A4 (en)
AU (1) AU2007350793A1 (en)
CA (1) CA2682589A1 (en)
WO (1) WO2008122098A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2381951B1 (en) * 2009-01-28 2015-12-23 Life Science Nutrition AS Compositions and methods of treating viral infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005110448A2 (en) * 2004-05-07 2005-11-24 Thermo Formulations Ltd. Nutritional composition for increasing creatine uptake in skeletal muscle
US20070020358A1 (en) * 2005-03-18 2007-01-25 Mower Thomas E Sports drink concentrate

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ALKHATIB ET AL: "Low molecular weight fucan prevents transplant coronaropathy in rat cardiac allograft model", TRANSPLANT IMMUNOLOGY, ELSEVIER, NL, vol. 16, no. 1, 1 June 2006 (2006-06-01), pages 14 - 19, XP005431154, ISSN: 0966-3274, DOI: 10.1016/J.TRIM.2006.03.003 *
OLSEN STEEN ET AL: "Creatine supplementation augments the increase in satellite cell and myonuclei number in human skeletal muscle induced by strength training.", THE JOURNAL OF PHYSIOLOGY 1 JUN 2006 LNKD- PUBMED:16581862, vol. 573, no. Pt 2, 1 June 2006 (2006-06-01), pages 525 - 534, XP002655440, ISSN: 0022-3751 *
RELIGA P ET AL: "Fucoidan inhibits smooth muscle cell proliferation and reduces mitogen-activated protein kinase activity.", EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY : THE OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY FOR VASCULAR SURGERY NOV 2000 LNKD- PUBMED:11112459, vol. 20, no. 5, November 2000 (2000-11-01), pages 419 - 426, XP002655441, ISSN: 1078-5884 *
See also references of WO2008122098A1 *

Also Published As

Publication number Publication date
WO2008122098A1 (en) 2008-10-16
AU2007350793A1 (en) 2008-10-16
EP2142195A1 (en) 2010-01-13
CA2682589A1 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
IL267138A (en) Improved cell composition and methods of making the same
ZA201103985B (en) Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
ZA201103983B (en) Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
IL202329A0 (en) Methods and compositions for stimulating cells
EP2424374A4 (en) Cleanser compositions and methods for using the same
EP2145000A4 (en) Reprogramming of somatic cells
ZA201008391B (en) Pluripotent cells
EP2152304A4 (en) Nanoemulsion therapeutic compositions and methods of using the same
EP2155859A4 (en) Formulations and methods for culturing embryonic stem cells
GB0622394D0 (en) Differentiation of pluripotent cells
HK1173968A1 (en) Stabilized liquid and lyophilized adamts13 formulations adamts13
EP2282648A4 (en) Prebiotic composition and methods of making and using the same
EP2370815A4 (en) Anti-inflammatory compositions and methods
EP2142205A4 (en) Compositions and methods for increasing vascularization
EP2235033A4 (en) Methods and compositions for increasing gene expression
EP2245942A4 (en) Composition containing cacao and spirulina
PT2222839E (en) Methods and compositions for modulating differentiation of pluripotential cells
EP2131868A4 (en) Cardiac-specific progenitor cells
EP2273993A4 (en) Methods and compositions for the intracerebroventricular administration of felbamate
EP2142195A4 (en) Composition for promoting the maintenance and function of muscle-specific progenitor cells
EP2115127A4 (en) Methods and compositions for improving the health of cells in culture
GB0805670D0 (en) Increasing the plasticity of stem cells
EP2516649A4 (en) Novel pneumovirus compositions and methods for using the same
EP2488624A4 (en) Stabilized surfactant-oxidant compositions and related methods
EP2475436A4 (en) Compositions, materials incorporating the compositions, and methods of using the compositions and materials

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20091026

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NORTHERN INNOVATIONS AND FORMULATIONS CORP.

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/164 20060101ALI20110804BHEP

Ipc: A23L 1/29 20060101ALI20110804BHEP

Ipc: A61K 36/03 20060101ALI20110804BHEP

Ipc: A61P 21/00 20060101ALI20110804BHEP

Ipc: A61K 31/197 20060101ALI20110804BHEP

Ipc: A61K 31/05 20060101ALI20110804BHEP

Ipc: A61K 31/737 20060101AFI20110804BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20110912

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20111201